Clinical case - Immune Check Point Inhibitor in the perioperative setting for MIBC

Dr. Benjamin Pradere (FR) and his colleagues discuss outcomes of using an Immune Check Point Inhibitor in the Perioperative Setting for muscle-invasive bladder cancer (MIBC).